MedPath

Five-Year Visual Function and Refractive Outcomes After Congenital Cataract Surgery

Recruiting
Conditions
Congenital Cataract
Pediatric Cataract
Registration Number
NCT07070037
Lead Sponsor
Jin Yang
Brief Summary

This prospective multicenter observational study aims to evaluate the 5-year visual function and refractive outcomes in children undergoing surgery for congenital cataract. Key outcomes include best-corrected visual acuity, stereopsis, refractive error, and axial length growth. The study will help identify long-term trends and prognostic indicators after early cataract intervention in pediatric patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Diagnosis of congenital cataract
  • Underwent cataract extraction before 1 year of age
  • Available for regular follow-up for at least 5 years postoperatively
  • Written informed consent from legal guardian
Exclusion Criteria
  • Acquired cataract or traumatic origin
  • Associated ocular malformations (e.g., microphthalmia, coloboma)
  • Systemic syndromes affecting vision (e.g., Down syndrome)
  • History of secondary surgery affecting visual outcome

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual AcuityParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

UDVA and BCVA will be assessed using age-appropriate optotypes (e.g., Snellen chart, ETDRS chart, or Lea symbols) and recorded in logMAR units at the last available follow-up, with a minimum duration of 5 years postoperatively.

axial lengthParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

AL

Refractive ErrorParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Refractive Error

Secondary Outcome Measures
NameTimeMethod
IOPParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

intraocular pressure

Corneal Curvature (K1 and K2) by PentacamParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Flat (K1) and steep (K2) corneal curvature values will be measured using Pentacam and recorded in diopters (D).

StereopsisParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Stereopsis will be assessed using age-appropriate tools (e.g., Randot Preschool or Titmus Fly Test) and reported in seconds of arc. Loss of stereopsis is defined as \>3000 arcsec.

white to whiteParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

WTW (mm)

anterior chamber depthParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

ACD(mm)

ComplicationsParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Any postoperative complications following congenital cataract surgery, including glaucoma, anterior capsular opacification (ACO), etc.

Central Corneal Thickness (CCT)Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Corneal pachymetry will be measured with Pentacam at the central point and reported in microns (µm).

Corneal Astigmatism MagnitudeParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Corneal astigmatism will be calculated from the difference between steep and flat meridians (K2-K1) using Pentacam data, and reported in diopters.

Binocular Fusion AssessmentParticipants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively.

Binocular fusion will be evaluated using the Worth 4-Dot test under near and distance conditions. Results will be categorized as "fusion", "suppression", or "alternation".

Trial Locations

Locations (1)

Eye and ENT hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Eye and ENT hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Xuanqiao Lin
Contact
15088920668
1532483480@qq.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.